Necrotizing soft tissue infections: APACHE II score, dissemination, and survival
- PMID: 17610007
- DOI: 10.1007/s00268-007-9132-1
Necrotizing soft tissue infections: APACHE II score, dissemination, and survival
Abstract
Background: First described more than a century ago, necrotizing soft tissue infections (NSTIs) continue to cause high mortality and morbidity. The aim of this study was to elucidate the factors affecting the outcome of patients presenting with an NSTI.
Methods: To determine the factors affecting mortality from NSTIs, the records of 67 patients were retrospectively assessed for the following parameters: age, sex, time between initiation of symptoms and admission to the clinic, presence of systemic coexisting disease, APACHE II score, origin of infection, dissemination of the NSTI, and method of therapy.
Results: The patients were 41 men (61.2%) and 26 women (38.8%) with a mean age of 54.9 +/- 1.73 years. The overall mortality rate was 49% (33/67). Multivariate analysis determined that APACHE II scores of 13 or higher (p = 0.001) and NSTI dissemination (p = 0.02) were risk factors affecting the mortality of patients with NSTIs.
Conclusion: By considering these two factors, more accurate outcome prediction may be possible, which may be useful for directing the management of patients with NSTIs.
Similar articles
-
Necrotizing soft-tissue infection: diagnosis and management.Clin Infect Dis. 2007 Mar 1;44(5):705-10. doi: 10.1086/511638. Epub 2007 Jan 22. Clin Infect Dis. 2007. PMID: 17278065 Review.
-
Can progression of odontogenic infections to cervical necrotizing soft tissue infections be predicted?Int J Oral Maxillofac Surg. 2017 Feb;46(2):181-188. doi: 10.1016/j.ijom.2016.09.016. Epub 2016 Oct 15. Int J Oral Maxillofac Surg. 2017. PMID: 27756512
-
Treatment and clinical outcomes in lower extremity necrotizing soft tissue infection.Eur J Trauma Emerg Surg. 2025 Mar 24;51(1):148. doi: 10.1007/s00068-025-02835-5. Eur J Trauma Emerg Surg. 2025. PMID: 40126628
-
Cervical Necrotizing Fasciitis, Diagnosis and Treatment of a Rare Life-Threatening Infection.Ear Nose Throat J. 2023 Mar;102(3):NP109-NP113. doi: 10.1177/0145561321991341. Epub 2021 Feb 11. Ear Nose Throat J. 2023. PMID: 33570428
-
Necrotizing soft tissue infections.Crit Care Clin. 2013 Oct;29(4):795-806. doi: 10.1016/j.ccc.2013.06.001. Epub 2013 Jul 25. Crit Care Clin. 2013. PMID: 24094377 Review.
Cited by
-
Case series of Fournier's gangrene: Affected body surface area - The underestimated prognostic factor.Ann Med Surg (Lond). 2017 Feb 27;16:19-22. doi: 10.1016/j.amsu.2017.02.043. eCollection 2017 Apr. Ann Med Surg (Lond). 2017. PMID: 28289541 Free PMC article.
-
The CRP/PAB ratio outperforms the LRINEC score in early diagnosis of Fournier's gangrene.Surg Pract Sci. 2024 Dec 8;19:100267. doi: 10.1016/j.sipas.2024.100267. eCollection 2024 Dec. Surg Pract Sci. 2024. PMID: 39844948 Free PMC article.
-
Fournier's Gangrene: Current Practices.ISRN Surg. 2012;2012:942437. doi: 10.5402/2012/942437. Epub 2012 Dec 3. ISRN Surg. 2012. PMID: 23251819 Free PMC article.
-
Evaluation and Management of Necrotizing Soft Tissue Infections.Infect Dis Clin North Am. 2017 Sep;31(3):497-511. doi: 10.1016/j.idc.2017.05.011. Infect Dis Clin North Am. 2017. PMID: 28779832 Free PMC article. Review.
-
Is hemoglobin A1c level effective in predicting the prognosis of Fournier gangrene?Urol Ann. 2016 Jul-Sep;8(3):343-7. doi: 10.4103/0974-7796.184905. Urol Ann. 2016. PMID: 27453658 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical